and Rhizome Atractylodes are principal medicine, and Agastache Rugosa and Gypsum Fibrosum are associate medicines in this prescription.
There are two species known as CP using in clinical practice, Cortex Phellodendron
Chinensis (CPC) derived from the dried bark of Phel-lodendron chinense Schneid.
Effect of a proprietary Magnolia and Phellodendron
extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial.
Isolation and identification of producing endophytic fungi of berberine from the plant Phellodendron
Flavoxine[TM] is a blend of two plant extracts, a proprietary extract of Phellodendron
amurense and a patented (U.
A new clinical trial on Next Pharmaceuticals' Relora found that the proprietary blend of Magnolia officinalis and Phellodendron
amurense significantly improved mood and other psychological states in moderately stressed subjects.
bark and Paeonia root extracts also reduced VSMC proliferation, although much less than Coptis rhizome.
Relora[R] is a natural proprietary blend of a patented extract of Magnolia officinalis and a proprietary extract of Phellodendron
5: Scutellariae radix (the root of Scutellaria baicalensis Georg stripped of its periderm), Coptidis rhizoma (the rootstock of Coptis japonica Makino stripped of its roots), Gardeniae fructus (the fruit of Gardenia jasminoides Ellis), and Phellodendri cortex (the bark of Phellodendron
amurense Rupr stripped of its periderm).
announced today the results of a study funded by the National Institutes of Health on the potential benefits of Nexrutine (R) (a proprietary extract from the bark of the Phellodendron
tree) on prostate cancer.
Relora(R) contains a patented extract from Magnolia officinalis and is combined with a proprietary extract of Phellodendron
Next Pharmaceuticals' product, Relora, made from a proprietary blend of Magnolia officinalis and Phellodendron
amurense, promotes healthy eating and weight management by quieting the hypothalamic-pituitary-adrenal axis.